Works matching IS 1522-8517 AND VI 21 AND IP 3 AND DT 2019

Results: 15

Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 380, doi. 10.1093/neuonc/noy162
By:
- Achey, Rebecca L;
- Gittleman, Haley;
- Schroer, Julia;
- Khanna, Vishesh;
- Kruchko, Carol;
- Barnholtz-Sloan, Jill S
Publication type:
Article
Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 360, doi. 10.1093/neuonc/noy195
By:
- Walker, Emily V;
- Davis, Faith G
Publication type:
Article
Forthcoming Meetings.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 415, doi. 10.1093/neuonc/noz019
Publication type:
Article
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 296, doi. 10.1093/neuonc/noy192
By:
- Grommes, Christian;
- Rubenstein, James L;
- DeAngelis, Lisa M;
- Ferreri, Andres J M;
- Batchelor, Tracy T
Publication type:
Article
Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 326, doi. 10.1093/neuonc/noy184
By:
- Eisemann, Tanja;
- Costa, Barbara;
- Harter, Patrick N;
- Wick, Wolfgang;
- Mittelbronn, Michel;
- Angel, Peter;
- Peterziel, Heike
Publication type:
Article
Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 392, doi. 10.1093/neuonc/noy124
By:
- Kok, Judith L;
- Teepen, Jop C;
- Leeuwen, Flora E van;
- Tissing, Wim J E;
- Neggers, Sebastian J C M M;
- Pal, Helena J van der;
- Loonen, Jacqueline J;
- Bresters, Dorine;
- Versluys, Birgitta;
- Heuvel-Eibrink, Marry M van den;
- Broeder, Eline van Dulmen-den;
- Loo, Margriet van der Heiden-van der;
- Aleman, Berthe M P;
- Daniels, Laurien A;
- Haasbeek, Cornelis J A;
- Hoeben, Bianca;
- Janssens, Geert O;
- Maduro, John H;
- Oldenburger, Foppe;
- Rij, Caroline van
Publication type:
Article
randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 348, doi. 10.1093/neuonc/noy200
By:
- Narita, Yoshitaka;
- Arakawa, Yoshiki;
- Yamasaki, Fumiyuki;
- Nishikawa, Ryo;
- Aoki, Tomokazu;
- Kanamori, Masayuki;
- Nagane, Motoo;
- Kumabe, Toshihiro;
- Hirose, Yuichi;
- Ichikawa, Tomotsugu;
- Kobayashi, Hiroyuki;
- Fujimaki, Takamitsu;
- Goto, Hisaharu;
- Takeshima, Hideo;
- Ueba, Tetsuya;
- Abe, Hiroshi;
- Tamiya, Takashi;
- Sonoda, Yukihiko;
- Natsume, Atsushi;
- Kakuma, Tatsuyuki
Publication type:
Article
Introduction of novel agents in the treatment of primary CNS lymphoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 306, doi. 10.1093/neuonc/noy193
By:
- Grommes, Christian;
- Nayak, Lakshmi;
- Tun, Han W;
- Batchelor, Tracy T
Publication type:
Article
Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 404, doi. 10.1093/neuonc/noy133
By:
- Kim, Jung Youn;
- Park, Ji Eun;
- Jo, Youngheun;
- Shim, Woo Hyun;
- Nam, Soo Jung;
- Kim, Jeong Hoon;
- Yoo, Roh-Eul;
- Choi, Seung Hong;
- Kim, Ho Sung
Publication type:
Article
Highlights from the Literature.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 293, doi. 10.1093/neuonc/noz020
By:
- Abounader, Roger;
- Bhat, Krishna;
- Hegi, Monika;
- Soffietti, Riccardo;
- Viapiano, Mariano
Publication type:
Article
Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 370, doi. 10.1093/neuonc/noy164
By:
- Korja, Miikka;
- Raj, Rahul;
- Seppä, Karri;
- Luostarinen, Tapio;
- Malila, Nea;
- Seppälä, Matti;
- Mäenpää, Hanna;
- Pitkäniemi, Janne
Publication type:
Article
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 337, doi. 10.1093/neuonc/noy185
By:
- Prabhu, Antony H;
- Kant, Shiva;
- Kesarwani, Pravin;
- Ahmed, Kamran;
- Forsyth, Peter;
- Nakano, Ichiro;
- Chinnaiyan, Prakash
Publication type:
Article
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 314, doi. 10.1093/neuonc/noy177
By:
- Lewis, Daniel;
- Roncaroli, Federico;
- Agushi, Erjon;
- Mosses, Dominic;
- Williams, Ricky;
- Li, Ka-loh;
- Zhu, Xiaoping;
- Hinz, Rainer;
- Atkinson, Ross;
- Wadeson, Andrea;
- Hulme, Sharon;
- Mayers, Helen;
- Stapleton, Emma;
- Lloyd, Simon K L;
- Freeman, Simon R;
- Rutherford, Scott A;
- Hammerbeck-Ward, Charlotte;
- Evans, D Gareth;
- Pathmanaban, Omar;
- Jackson, Alan
Publication type:
Article
Brain and central nervous system tumor statistics: access to accurate data for all countries is critical!
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 291, doi. 10.1093/neuonc/noy205
By:
- Barnholtz-Sloan, Jill S
Publication type:
Article
Bespoke immunotherapy: how close are we?
Published in:
Neuro-Oncology, 2019, v. 21, n. 3, p. 289, doi. 10.1093/neuonc/noz017
By:
- Jackson, Christina;
- Lim, Michael
Publication type:
Article